Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
26.08. | Sona Nanotech Inc: Sona completes treatment of first patient cohort in FS | 2 | Stockwatch | ||
25.08. | Sona Nanotech advances cancer therapy with promising early results | 1 | The Market Herald Canada | ||
25.08. | Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial | 569 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
23.07. | Sona Nanotech Inc: Sona receives ethics board OK for THT pilot human study | 1 | Stockwatch | ||
23.07. | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 523 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
08.07. | Sona Nanotech doses first patient in groundbreaking cancer therapy trial | 1 | The Market Herald Canada | ||
08.07. | Sona Nanotech Inc: Sona completes first dosing in early FS trial | 1 | Stockwatch | ||
07.07. | Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy | 704 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
27.06. | Sona Nanotech Inc: Sona receives committee approval for melanoma trial | 2 | Stockwatch | ||
27.06. | Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial | 483 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
17.06. | Sona Nanotech Inc: Sona to conduct FS trial for targeted hyperthermia | 7 | Stockwatch | ||
16.06. | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 436 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen | |
28.05. | Sona Nanotech Inc: Sona completes toxicity study on its gold nanorods | 14 | Stockwatch | ||
27.05. | Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study | 569 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety... ► Artikel lesen | |
16.05. | Sona Nanotech Inc: Sona completes bacterial endotoxin test on nanorods | 4 | Stockwatch | ||
15.05. | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 862 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen | |
07.05. | BioVaxys & Sona Nanotech Enter Research Collaboration | 3 | Contract Pharma | ||
07.05. | Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration | 726 | Newsfile | Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)... ► Artikel lesen | |
07.05. | BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration | 894 | PR Newswire | VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc.... ► Artikel lesen | |
01.05. | Sona Nanotech Inc: Sona Nanotech grants options to buy 2.13 million shares | 1 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 24,000 | -3,23 % | Formycon-Aktie verliert 2,64 Prozent (23,95 €) | Im deutschen Wertpapierhandel notiert das Wertpapier von Formycon gegenwärtig leichter. Zuletzt zahlten Investoren für das Papier 23,95 Euro. Der Anteilsschein von Formycon verzeichnet zur Stunde einen... ► Artikel lesen | |
OBDUCAT | 0,019 | -5,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
SOLESENCE | 3,580 | -1,65 % | Solesence-Aktionäre bestätigen Direktoren und billigen Eigenkapitalplan | ||
GOMSPACE | 1,236 | -7,48 % | GomSpace Group AB: GomSpace Reports Strong Q2 Performance with Growth and Profitability | GomSpace releases Q2 2025 and half-year report, reporting strong year-on-year revenue growth and positive EBITDA and EBIT year-to-date.
SECOND QUARTER OF 2025
Order intake increased by 29% to 257... ► Artikel lesen | |
ONTO INNOVATION | 88,00 | -3,83 % | EQS-Media: LPKF Laser & Electronics SE: Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran | EQS-Media / 02.04.2025 / 09:00 CET/CEST
Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran
LPKF schließt sich dem Packaging Applications... ► Artikel lesen | |
KOPIN | 1,701 | -5,87 % | Kopin Corporation Announces Agreement for $15 Million Strategic Investment From Theon International Plc to Accelerate Global Defense Innovation | Kopin gains significant access to the European and NATO defense market
Accelerates development of critical technologies
Further strengthens Kopin's balance sheet
Fixed conversion... ► Artikel lesen | |
GAUZY | 5,160 | -5,23 % | GAUZY LTD: Gauzy Selected as Exclusive Smart Glass Supplier to One of the Top 3 U.S. Financial Institutions for Nationwide Commercial Offices | ||
DOTZ NANO | 0,033 | 0,00 % | XFRA 57N: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDOTZ NANO LTD 57N... ► Artikel lesen | |
VEECO INSTRUMENTS | 20,600 | -1,90 % | Benchmark Reaffirms 'Buy' Rating on Veeco Instruments Inc. (VECO); Sets $28 PT | ||
FENDX TECHNOLOGIES | 0,368 | +7,76 % | FendX Technologies Inc.: FendX Advances Medical Catheter Coating Innovation: Provisional Patent Filed | Vancouver, British Columbia--(Newsfile Corp. - August 26, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTD) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
NVE | 55,50 | 0,00 % | Dividendenbekanntmachungen (04.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERIPRISE FINANCIAL INC US03076C1062 1,6 USD 1,3806 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0258 EUR ATLANTIC UNION... ► Artikel lesen | |
ACACIA RESEARCH | 2,840 | 0,00 % | Acacia Research und Partner entwickeln eine mit Bitcoin gesicherte Gewerbedarlehensstrategie | ||
ADVANCE ZINCTEK | 0,615 | -7,52 % | ADVANCE ZINCTEK LIMITED: Corporate Governance Statement | ||
LAMPETIA | 0,144 | +7,46 % | EQS-News: LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Jahresergebnis
LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis
30.06.2025 / 16:18 CET/CEST
Für den... ► Artikel lesen | |
NANOFOCUS | 1,240 | 0,00 % | NanoFocus: Hauptaktionär plant Squeeze-out | Die Carl Mahr Holding GmbH hat ein offizielles Verlangen auf Durchführung eines aktienrechtlichen Squeeze-outs bei der NanoFocus AG übermittelt. Demnach soll die Hauptversammlung einen Beschluss fassen... ► Artikel lesen |